RVL Pharmaceuticals PLC
NASDAQ:RVLP
RVL Pharmaceuticals PLC
Total Other Income
RVL Pharmaceuticals PLC
Total Other Income Peer Comparison
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
RVL Pharmaceuticals PLC
NASDAQ:RVLP
|
Total Other Income
$7.5m
|
CAGR 3-Years
104%
|
CAGR 5-Years
75%
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Total Other Income
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Total Other Income
-$149m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-54%
|
|
Pfizer Inc
NYSE:PFE
|
Total Other Income
-$5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
50%
|
CAGR 10-Years
N/A
|
|
Merck & Co Inc
NYSE:MRK
|
Total Other Income
$1.5B
|
CAGR 3-Years
48%
|
CAGR 5-Years
41%
|
CAGR 10-Years
18%
|
|
Eli Lilly and Co
NYSE:LLY
|
Total Other Income
$456.1m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
3%
|
CAGR 10-Years
20%
|
See Also
What is RVL Pharmaceuticals PLC's Total Other Income?
Total Other Income
7.5m
USD
Based on the financial report for Dec 31, 2022, RVL Pharmaceuticals PLC's Total Other Income amounts to 7.5m USD.
What is RVL Pharmaceuticals PLC's Total Other Income growth rate?
Total Other Income CAGR 5Y
75%
Over the last year, the Total Other Income growth was 78%. The average annual Total Other Income growth rates for RVL Pharmaceuticals PLC have been 104% over the past three years , 75% over the past five years .